CIK: 1619252 - Address: C/O Allovir, Inc., P.O. Box 44, 1661 Massachusetts Ave., Lexington, MA 02420
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11610-42-9-15-5
S%wins505083407510066

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/6/24 16:15
11/5/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-20.86490-20501D
10/23/24 16:15
10/21/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.m-10.77290-10503D
10/4/24 16:15
10/3/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.8148000504D
8/20/24 16:15
8/19/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.7595000505D
8/7/24 16:15
8/5/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-20.73480-20505D
7/23/24 16:25
7/19/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.m-10.74420-10508D
7/3/24 16:14
7/2/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.7200000509D
5/21/24 16:33
5/17/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.7493000509D
5/7/24 16:15
5/3/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-20.79600-20510D
4/23/24 16:15
4/19/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.m-10.75030-10512D
4/4/24 16:15
4/2/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.7720000513D
2/22/24 16:16
2/20/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.6952000514D
2/6/24 16:40
2/5/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-60.67000-9-2514D
1/25/24 16:15
1/23/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-10.67080-10523D
1/8/24 16:15
1/4/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.6390000524D
1/23/23 19:00
1/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.m-135.090-3-1437M
11/16/22 17:10
11/14/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-218.910-2-1440I
10/26/22 16:15
10/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.a-59.360-10249D
10/24/22 18:24
10/19/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-59.360-10442D
3/3/21 20:35
3/1/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-23338.780-6-2387I
3/1/17 19:45
2/27/17
ALXNAlexion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMiller EdwardCTOSVP,ChieS.dm-78131.4833-1-319D-27-7110-3311-1-4-10
2/8/17 16:39
2/6/17
ALXNAlexion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMiller EdwardCTOSVP,ChieS-131125.7033-1-615D-27-8-6-10-6-1-1120-1
9/9/16 18:23
9/9/16
ALXNAlexion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMiller EdwardCTOSVP,ChieS-47128.32330-217D-19-24-5-60-22544012
3/1/16 18:33
2/29/16
ALXNAlexion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMiller EdwardCTOSVP,ChieS.d-46138.91330-217D-23-22-22-23-111-2-11-1-110-15-14
2/8/16 19:57
2/5/16
ALXNAlexion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMiller EdwardCTOSVP,ChieS-150143.0233-1-714D-8-20-25-19-24-10-64-2111-1-8
9/10/15 20:45
9/9/15
ALXNAlexion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMiller EdwardCTOSVP,ChieS-66179.55330-56D526-41-14-7-4-20-2-410-20-24

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact